NASDAQ:CYBE | Market Exclusive

Home Tags NASDAQ:CYBE

CyberOptics Corporation (NASDAQ:CYBE) Files An 8-K Results of Operations and Financial...

ME Staff 8-k - July 23, 2020 0

CyberOptics Corporation (NASDAQ:CYBE) Files An 8-K Results of Operations and Financial...

ME Staff 8-k - July 2, 2019 0

CyberOptics Corporation (NASDAQ:CYBE) price target raised to $25.00 by Craig Hallum

ME Staff - July 26, 2018 0

CyberOptics Corporation (NASDAQ:CYBE) had its Buy rating reiterated by Lake Street...

ME Staff - July 26, 2018 0

CyberOptics Corporation (NASDAQ:CYBE) Files An 8-K Departure of Directors or Certain...

ME Staff 8-k - May 15, 2018 0

CyberOptics Corporation (NASDAQ:CYBE) Files An 8-K Results of Operations and Financial...

ME Staff 8-k - April 24, 2018 0

Analyst Activity – Lake Street Capital Lowers Its Price Target On...

ME Staff - October 3, 2017 0

CyberOptics Corporation (NASDAQ:CYBE) Files An 8-K Results of Operations and Financial...

ME Staff 8-k - October 2, 2017 0

Analyst Activity – Dougherty & Co Lowers Its Price Target On...

ME Staff - July 28, 2017 0

Analyst Activity – Dougherty & Co Lowers Its Price Target On...

ME Staff - July 28, 2017 0

12 Page 1 of 2

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

June 29, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

June 16, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

May 11, 2025

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: NASDAQ:CYBE

CyberOptics Corporation (NASDAQ:CYBE) Files An 8-K Results of Operations and Financial...

CyberOptics Corporation (NASDAQ:CYBE) Files An 8-K Results of Operations and Financial...

CyberOptics Corporation (NASDAQ:CYBE) price target raised to $25.00 by Craig Hallum

CyberOptics Corporation (NASDAQ:CYBE) had its Buy rating reiterated by Lake Street...

CyberOptics Corporation (NASDAQ:CYBE) Files An 8-K Departure of Directors or Certain...

CyberOptics Corporation (NASDAQ:CYBE) Files An 8-K Results of Operations and Financial...

Analyst Activity – Lake Street Capital Lowers Its Price Target On...

CyberOptics Corporation (NASDAQ:CYBE) Files An 8-K Results of Operations and Financial...

Analyst Activity – Dougherty & Co Lowers Its Price Target On...

Analyst Activity – Dougherty & Co Lowers Its Price Target On...

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY